Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 GIP-GLP1 receptor agonist shows promise.

× No keyword cloud information.

3 in total

1. Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial.

Authors: Tadej Battelino; Richard M Bergenstal; Angel Rodríguez; Laura Fernández Landó; Ross Bray; Zhentao Tong; Katelyn Brown
Journal: Lancet Diabetes Endocrinol Date: 2022-04-22 Impact factor: 44.867

2. Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial.

Authors: Amalia Gastaldelli; Kenneth Cusi; Laura Fernández Landó; Ross Bray; Bram Brouwers; Ángel Rodríguez
Journal: Lancet Diabetes Endocrinol Date: 2022-04-22 Impact factor: 44.867

3. Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial.

Authors: Tim Heise; Andrea Mari; J Hans DeVries; Shweta Urva; Jing Li; Edward John Pratt; Tamer Coskun; Melissa K Thomas; Kieren J Mather; Axel Haupt; Zvonko Milicevic
Journal: Lancet Diabetes Endocrinol Date: 2022-04-22 Impact factor: 44.867

3 in total

1 in total

Review 1. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review.

Authors: Vivek P Chavda; Jinal Ajabiya; Divya Teli; Joanna Bojarska; Vasso Apostolopoulos
Journal: Molecules Date: 2022-07-05 Impact factor: 4.927

1 in total